Exploiting sweet relief for preeclampsia by targeting autophagy-lysosomal machinery and proteinopathy DOI Creative Commons
Zheping Huang, Shi‐Bin Cheng,

Sukanta Jash

и другие.

Experimental & Molecular Medicine, Год журнала: 2024, Номер 56(5), С. 1206 - 1220

Опубликована: Май 17, 2024

Abstract The etiology of preeclampsia (PE), a severe complication pregnancy with several clinical manifestations and high incidence maternal fetal morbidity mortality, remains unclear. This issue is major hurdle for effective treatment strategies. We recently demonstrated that PE exhibits an Alzheimer-like impaired autophagy proteinopathy in the placenta. Targeting these pathological pathways may be novel therapeutic strategy PE. Stimulation natural disaccharide trehalose its lacto analog lactotrehalose hypoxia-exposed primary human trophoblasts restored autophagy, inhibited accumulation toxic protein aggregates, ultrastructural features autophagosomes autolysosomes. Importantly, onset PE-like humanized mouse model by normalizing inhibiting aggregation These disaccharides autophagy-lysosomal biogenesis machinery increasing nuclear translocation master transcriptional regulator TFEB. RNA-seq analysis placentas mice indicated normalization PE-associated transcriptome profile response to lactotrehalose. In summary, our results provide molecular rationale patients identify as promising options this complication.

Язык: Английский

Deoxynivalenol Induces Intestinal Epithelial Barrier Damage through RhoA/ROCK Pathway-Mediated Apoptosis and F-Actin-Associated Tight Junction Disruption DOI
Chenjiao Miao,

Zuoyao Wu,

Sun Ya-fei

и другие.

Journal of Agricultural and Food Chemistry, Год журнала: 2024, Номер unknown

Опубликована: Апрель 9, 2024

Deoxynivalenol (DON) poses a serious global food safety risk due to its high toxicity and contamination rate. It disrupts the intestinal epithelial barrier, allowing exogenous toxins enter circulation resulting in sepsis systemic toxicity. In this research, 32 male Kunming mice Porcine Small Intestinal Epithelial (IPEC-J2) cells were treated with DON at 0–4.8 mg/kg (7 d) 0–12 μM (24 h), respectively. Histopathological results revealed that disrupted causing apoptosis tight junction (TJ) injury. Immunofluorescence protein expression showed DON-induced p53-dependent mitochondrial pathway fibrillar actin (F-actin)-associated TJ injury RhoA/ROCK activated jejunal tissue IPEC-J2 cells. Pretreatment RhoA or ROCK inhibitors (Rosin Y-27632) maintained F-actin-associated Thus, induces damage barrier through pathway-mediated disruption.

Язык: Английский

Процитировано

5

The functional and molecular roles of p75 neurotrophin receptor (p75NTR) in epilepsy DOI Creative Commons
Areej Turkistani, Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb

и другие.

Journal of Central Nervous System Disease, Год журнала: 2024, Номер 16

Опубликована: Апрель 22, 2024

Epilepsy is a chronic neurological disorder manifested by recurring unprovoked seizures resulting from an imbalance in the inhibitory and excitatory neurotransmitters brain. The process of epileptogenesis involves complex interplay between reduction gamma-aminobutyric acid (GABA) enhancement glutamate. Pro-BDNF/p75 NTR expression augmented both glial cells neurons following epileptic status epileptics (SE). Over-expression p75 linked with pathogenesis epilepsy, augmentation pro-BDNF/p75 implicated epilepsy. However, precise mechanistic function epilepsy has not been completely elucidated. Therefore, this review aimed to revise pathway

Язык: Английский

Процитировано

5

New insights on the regulators and inhibitors of RhoA-ROCK signalling in Parkinson’s disease DOI

Nandita Ravichandran,

Mahalaxmi Iyer, Deenathayalan Uvarajan

и другие.

Metabolic Brain Disease, Год журнала: 2025, Номер 40(1)

Опубликована: Янв. 7, 2025

Язык: Английский

Процитировано

0

RhoA/ROCK/GSK3β Signaling: A Keystone in Understanding Alzheimer’s Disease DOI Creative Commons

Milan M. Medd,

Jiang Yon,

Hongxin Dong

и другие.

Current Issues in Molecular Biology, Год журнала: 2025, Номер 47(2), С. 124 - 124

Опубликована: Фев. 14, 2025

Alzheimer's disease (AD) is a neurodegenerative characterized by progressive cognitive decline and loss of neuronal integrity. Emerging evidence suggests that RhoA, Rho-associated coiled-coil kinase (ROCK), their downstream effector molecule glycogen synthase 3β (GSK3β) interact within complex signaling pathway (RhoA/ROCK/GSK3β) plays crucial role in the pathogenesis AD. small GTPase, along with its effector, ROCK, regulates various cellular processes, including actin cytoskeleton dynamics, apoptosis, synaptic plasticity. GSK3β, serine/threonine kinase, key function AD pathology, regulation tau phosphorylation amyloid-beta cleavage. Overactive GSK3β has been closely linked to hyperphosphorylation, neurodegeneration, progression Thus, considered as promising therapeutic target for treating mitigating impairment. However, clinical trials have faced considerable challenges due complexity specific inhibition GSK3β. In this review, we summarize literature regarding relationship RhoA/ROCK pathways pathogenesis. We further discuss recent findings sTREM2-transgelin-2 (TG2) axis potential mediator provide our review on novel targeting strategy

Язык: Английский

Процитировано

0

Gastrodin Mitigates Ketamine-Induced Inhibition of F-Actin Remodeling and Cell Migration by Regulating the Rho Signaling Pathway DOI Creative Commons
Ping-Cheng Shih, I‐Shiang Tzeng, Yi-Chyan Chen

и другие.

Biomedicines, Год журнала: 2025, Номер 13(3), С. 649 - 649

Опубликована: Март 6, 2025

Background/Objects: Rho signaling plays a role in calcium-regulated cytoskeletal reorganization and cell movement, processes linked to neuronal function cancer metastasis. Gastrodia elata, traditional herbal medicine, can regulate glutamate-induced calcium influx PC12 cells influence by modulating cytoskeleton remodeling via the monoaminergic system signaling. This study investigates effects of gastrodin, key component on signaling, remodeling, migration B35 C6 cells. It also explores gastrodin’s impact prefrontal cortex Sprague Dawley rats. Methods: cells, rats were treated with ketamine, or both. The expression examined proteins from analyzed using immunoblotting. Immunofluorescent staining was applied detect phosphorylation RhoGDI1. F-actin stained phalloidin-488 staining. Cell Transwell wound-healing assays. Results: Gastrodin reversed ketamine-induced regulation mobility inhibition, condensation, modulation including GDP dissociation inhibitor 1 (RhoGDI1); family protein (Ras homolog member A (RhoA); division control 42 (CDC42); Ras-related C3 botulinum toxin substrate 1(Rac1)); rho-associated, coiled-coil-containing kinase (ROCK1); neural Wiskott–Aldrich syndrome (NWASP); myosin light chain 2 (MLC2); profilin1 (PFN1); cofilin-1 (CFL1) Similar modulations observed Conclusions: Our findings show that gastrodin counteracts disruptions dynamics, regulating components like RhoGDI1, ROCK1, MLC2, PFN1, CFL1. suggests potential as comprehensive regulator cellular

Язык: Английский

Процитировано

0

Biochemical Pathways of Cellular Mechanosensing/Mechanotransduction and Their Role in Neurodegenerative Diseases Pathogenesis DOI Creative Commons
Ilaria Tortorella, Chiara Argentati, Carla Emiliani

и другие.

Cells, Год журнала: 2022, Номер 11(19), С. 3093 - 3093

Опубликована: Окт. 1, 2022

In this review, we shed light on recent advances regarding the characterization of biochemical pathways cellular mechanosensing and mechanotransduction with particular attention to their role in neurodegenerative disease pathogenesis. While mechanistic components these are mostly uncovered today, crosstalk between mechanical forces soluble intracellular signaling is still not fully elucidated. Here, recapitulate general concepts mechanobiology mechanisms that govern processes, examine stimuli response, highlighting effect organelles' homeostasis dysfunction. particular, discuss current knowledge about translation mechanosignaling into signaling, focusing those diseases encompass metabolic accumulation mutant proteins have as primary characteristics formation pathological aggregates, such Alzheimer's Disease, Huntington's Amyotrophic Lateral Sclerosis Parkinson's Disease. Overall, findings elucidate how may be crucial understand pathogenic underlying emphasize importance for identifying potential therapeutic targets.

Язык: Английский

Процитировано

22

Neurotrophic factor-based pharmacological approaches in neurological disorders DOI Creative Commons
Vanessa Castelli, Margherita Alfonsetti, Michele d’Angelo

и другие.

Neural Regeneration Research, Год журнала: 2022, Номер 18(6), С. 1220 - 1220

Опубликована: Окт. 14, 2022

Aging is a physiological event dependent on multiple pathways that are linked to lifespan and processes leading cognitive decline. This process represents the major risk factor for aging-related diseases such as Alzheimer's disease, Parkinson's ischemic stroke. The incidence of all these pathologies increases exponentially with age. Research aging biology has currently focused elucidating molecular mechanisms development those pathologies. Cognitive deficit neurodegeneration, common features pathologies, related alteration activity levels neurotrophic factors, brain-derived factor, nerve growth glial cell-derived factor. For this reason, treatments modulate neurotrophin have acquired great deal interest in preventing neurodegeneration promoting neural regeneration several neurological diseases. Those include both direct administration factors induced expression viral vectors, neurotrophins' binding biomaterials or other molecules increase their bioavailability but also cell-based therapies. Considering crucial role here we discuss involvement most brain recent therapeutic approaches provide sustained support.

Язык: Английский

Процитировано

19

Network pharmacology reveals that Berberine may function against Alzheimer’s disease via the AKT signaling pathway DOI Creative Commons
Wei Wei,

Jiuxiu Yao,

Tingting Zhang

и другие.

Frontiers in Neuroscience, Год журнала: 2023, Номер 17

Опубликована: Май 4, 2023

Objective To investigate the mechanism underlying effects of berberine (BBR) in treatment Alzheimer’s disease (AD). Methods 3 × Tg AD mice were treated with BBR for months, then open field test (OFT), novel object recognition (NOR) and Morris water maze (MWM) performed to assess behavioral performance. Hematoxylin–eosin (HE) staining, Nissl staining used examine histopathological changes. The pharmacological molecular properties obtained from TCMSP database. BBR-associated targets identified using PharmMapper (PM), comparative toxicogenomics database (CTD), DisGeNet human gene (GeneCards). Core networks PPI network functional enrichment analyses. AutoDock software was model interaction between potential targets. Finally, RT-qPCR, western blotting validate expression core Results Behavioral experiments, HE have shown that can improve memory task performance neuronal damage hippocampus mice. 117 identified, 43 genes downstream analysis combination results protein–protein (PPI) analysis. 2,230 biological processes (BP) terms, 67 cell components (CC) 243 function (MF) terms 118 KEGG identified. ALB , EGFR CASP3 five PI3K-AKT signaling pathway including AKT1 HSP90AA1 SRC HRAS IGF1 selected by analysis, validated docking RT-q PCR as further Akt1 mRNA levels significantly decreased increased after ( p < 0.05). Besides, AKT ERK phosphorylation group, their levels. Conclusion AD. may exert a neuroprotective effect modulating pathways.

Язык: Английский

Процитировано

12

Impact of 17-alpha ethinyl estradiol (EE2) and diethyl phthalate (DEP) exposure on microRNAs expression and their target genes in differentiated SH-SY5Y cells DOI Creative Commons
Agnese Graziosi,

Camilla Corrieri,

Giulia Sita

и другие.

Scientific Reports, Год журнала: 2025, Номер 15(1)

Опубликована: Янв. 21, 2025

Язык: Английский

Процитировано

0

Qiangji Decoction mitigates neuronal damage, synaptic and mitochondrial dysfunction in SAMP8 mice through the regulation of ROCK2/Drp1-mediated mitochondrial dynamics DOI

Bixuan Lai,

Dan Wu, Qiang Xiao

и другие.

Journal of Ethnopharmacology, Год журнала: 2025, Номер unknown, С. 119424 - 119424

Опубликована: Янв. 1, 2025

Язык: Английский

Процитировано

0